Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1932365 | 1.00 | LMNA (0.42) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL1931307 | 1.00 | LMNA (0.42) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL104414 | 1.00 | LMNA (0.42) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL1931551 | 1.00 | LMNA (0.42) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL20291795 | 1.00 | LMNA (0.42) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL20299937 | 1.00 | LMNA (0.42) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL1932317 | 1.00 | LMNA (0.42) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL1932939 | 1.00 | LMNA (0.42) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL2761836 | 1.00 | LMNA (0.42) | LMNATSHRTHRBDNM1OPRM1 | |
| Water SCHEMBL28197602 | 0.97 | LMNA (0.41) | LMNATSHRTHRBDNM1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 490 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240279633-A1 | PROTEASE COMPOSITIONS AND METHODS OF USE THEREOF | NeoGeneStar LLC (US) | 2024-08-22 | — | — | US | claimed |
| US-11939610-B2 | Protease compositions and methods of use thereof | NeoGeneStar LLC (US) | 2024-03-26 | — | — | US | claimed |
| US-11370985-B2 | Multicomponent diesel composition | NESTE OYJ (FI) | 2022-06-28 | — | — | US | claimed |
| US-11319500-B2 | Multicomponent diesel composition | NESTE OYJ (FI) | 2022-05-03 | — | — | US | claimed |
| US-20220081683-A1 | PROTEASE COMPOSITIONS AND METHODS OF USE THEREOF | NeoGeneStar LLC (US) | 2022-03-17 | — | — | US | claimed |
| US-20210292669-A1 | A MULTICOMPONENT DIESEL COMPOSITION | NESTE OYJ (FI) | 2021-09-23 | — | — | US | claimed |
| CN-110099986-B | Multi-component diesel fuel composition | 耐思特公司 | 2021-07-09 | — | — | CN | claimed |
| CN-110088249-B | Multi-component diesel fuel composition | 耐思特公司 | 2021-06-25 | — | — | CN | claimed |
| EP-3555241-B1 | A MULTICOMPONENT DIESEL COMPOSITION | NESTE OYJ (FI) | 2020-11-11 | — | — | EP | claimed |
| EP-3555240-B1 | A MULTICOMPONENT DIESEL COMPOSITION | NESTE OYJ (FI) | 2020-10-14 | — | — | EP | claimed |
| WO-2002102351-A2 | COMPOSITIONS COMPRISING A CATIONIC HOMOPOLYMER AND THEIR USE FOR STABILIZATION OF AN OXIDIZING SOLUTION | L'OREAL S.A. (FR) | 2002-12-27 | — | — | WO | claimed |
| EP-1217988-A1 | PROTEINIC DRUG DELIVERY SYSTEM USING MEMBRANE MIMETICS | Generex Pharmaceuticals Inc. (CA) | 2002-07-03 | — | — | EP | claimed |
| US-6290987-B1 | ALKALI METAL ALKYL SULFATE, AT LEAST ONE MEMBRANE MIMETIC AMPHIPHILE, AND AT LEAST ONE PHOSPHOLIPID. | GENEREX PHARMACEUTICALS, INC. (CA) | 2001-09-18 | — | — | US | claimed |
| EP-1115381-A1 | PROTEINIC DRUG DELIVERY SYSTEM USING MEMBRANE MIMETICS | Generex Pharmaceuticals Inc. (CA) | 2001-07-18 | — | — | EP | claimed |
| US-6217885-B1 | SKIN DISORDERS; THERAPY FOR INSECT BITES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-04-17 | — | — | US | claimed |
| WO-2001017506-A1 | PROTEINIC DRUG DELIVERY SYSTEM USING MEMBRANE MIMETICS | GENEREX PHARMACEUTICALS INC. (CA) | 2001-03-15 | — | — | WO | claimed |
| US-6193997-B1 | HYALURONIC ACID AMPHIPHILE AND PHOSPHOLIPID; ADMINISTERING TO MOUTH AND NOSE MUCOUS MEMBRANES; LIPOSOME WITH MULTILAMELLAR VESICLES | GENEREX PHARMACEUTICALS INC. (CA) | 2001-02-27 | — | — | US | claimed |
| US-6132955-A | Method for derivitizing electrodes and assay methods using such derivitized electrodes | IGEN INTERNATIONAL, INC. (US) | 2000-10-17 | — | — | US | claimed |
| WO-2000018371-A1 | PROTEINIC DRUG DELIVERY SYSTEM USING MEMBRANE MIMETICS | GENEREX PHARMACEUTICALS INC. (CA) | 2000-04-06 | — | — | WO | claimed |
| EP-0475160-B1 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 1996-02-14 | — | — | EP | claimed |